Brett W Sperry1, Michael N Vranian2, Rory Hachamovitch2, Hariom Joshi3, Meghann McCarthy3, Asad Ikram2, Mazen Hanna2. 1. Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Electronic address: sperryb@ccf.org. 2. Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. 3. Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Abstract
BACKGROUND: Low voltage electrocardiography (ECG) coupled with increased ventricular wall thickness is the hallmark of cardiac amyloidosis. However, patient characteristics influencing voltage in the general population, including bundle branch block, have not been evaluated in amyloid heart disease. METHODS: A retrospective analysis was performed of patients with newly diagnosed cardiac amyloidosis from 2002 to 2014. ECG voltage was calculated using limb (sum of QRS complex in leads I, II and III) and precordial (Sokolow: S in V1 plus R in V5-V6) criteria. The associations between voltage and clinical variables were tested using multivariable linear regression. A Cox model assessed the association of voltage with mortality. RESULTS: In 389 subjects (transthyretin ATTR 186, light chain AL 203), 30% had conduction delay (QRS >120ms). In those with narrow QRS, 68% met low limb, 72% low Sokolow and 57% both criteria, with lower voltages found in AL vs ATTR. LV mass index as well as other typical factors that impact voltage (age, sex, race, hypertension, BSA, and smoking) in the general population were not associated with voltage in this cardiac amyloidosis cohort. Patients with LBBB and IVCD had similar voltages when compared to those with narrow QRS. Voltage was significantly associated with mortality (p<0.001 for both criteria) after multivariable adjustment. CONCLUSION: Classic predictors of ECG voltage in the general population are not valid in cardiac amyloidosis. In this cohort, the prevalence estimates of ventricular conduction delay and low voltage are higher than previously reported. Voltage predicts mortality after multivariable adjustment.
BACKGROUND: Low voltage electrocardiography (ECG) coupled with increased ventricular wall thickness is the hallmark of cardiac amyloidosis. However, patient characteristics influencing voltage in the general population, including bundle branch block, have not been evaluated in amyloid heart disease. METHODS: A retrospective analysis was performed of patients with newly diagnosed cardiac amyloidosis from 2002 to 2014. ECG voltage was calculated using limb (sum of QRS complex in leads I, II and III) and precordial (Sokolow: S in V1 plus R in V5-V6) criteria. The associations between voltage and clinical variables were tested using multivariable linear regression. A Cox model assessed the association of voltage with mortality. RESULTS: In 389 subjects (transthyretin ATTR 186, light chain AL 203), 30% had conduction delay (QRS >120ms). In those with narrow QRS, 68% met low limb, 72% low Sokolow and 57% both criteria, with lower voltages found in AL vs ATTR. LV mass index as well as other typical factors that impact voltage (age, sex, race, hypertension, BSA, and smoking) in the general population were not associated with voltage in this cardiac amyloidosis cohort. Patients with LBBB and IVCD had similar voltages when compared to those with narrow QRS. Voltage was significantly associated with mortality (p<0.001 for both criteria) after multivariable adjustment. CONCLUSION: Classic predictors of ECG voltage in the general population are not valid in cardiac amyloidosis. In this cohort, the prevalence estimates of ventricular conduction delay and low voltage are higher than previously reported. Voltage predicts mortality after multivariable adjustment.
Authors: Julia Kozlitina; Sonia Garg; Mark H Drazner; Susan A Matulevicius; Colby Ayers; John Overton; Jeffrey Reid; Aris Baras; Krishnasree Rao; Ambarish Pandey; Jarett Berry; James A de Lemos; Justin L Grodin Journal: J Card Fail Date: 2021-10-09 Impact factor: 5.712
Authors: Brett W Sperry; Matthew H Gonzalez; Richard Brunken; Manuel D Cerqueira; Mazen Hanna; Wael A Jaber Journal: J Nucl Cardiol Date: 2018-01-17 Impact factor: 5.952
Authors: Temidayo Abe; Eric Y Chang; Gabrielle De Allie; Taiwo Ajose; Chukwuemeka Nwokike; Nicolas Bakinde Journal: SAGE Open Med Case Rep Date: 2020-05-20
Authors: Michele Orini; Adam J Graham; Ana Martinez-Naharro; Christopher M Andrews; Antonio de Marvao; Ben Statton; Stuart A Cook; Declan P O'Regan; Philip N Hawkins; Yoram Rudy; Marianna Fontana; Pier D Lambiase Journal: J Am Heart Assoc Date: 2019-09-08 Impact factor: 5.501